Factors Associated with Infection of the Central Venous Catheter for Hemodialysis in Ouagadougou (Burkina Faso)

Gérard Coulibaly; Gildas Ilboudo; Kongnimissom Apoline Sondo; Adama Roger Karambiri; François P Kissou; Adama Lengani

doi:10.4236/ojbd.2015.54009

Home > Journals > Medicine & Healthcare > OJBD

Open Journal of Blood Diseases > Vol.5 No.4, December 2015

Factors Associated with Infection of the Central Venous Catheter for Hemodialysis in Ouagadougou (Burkina Faso) ()

Gérard Coulibaly^1*, Gildas Ilboudo¹, Kongnimissom Apoline Sondo², Adama Roger Karambiri¹, François P Kissou¹, Adama Lengani¹

¹Department of Nephrology and Hemodialysis, Yalgado Ouedraogo University Hospital Center (YO-UHC), Ouagadougou, Burkina Faso.
²Department of Infectious Diseases, Yalgado Ouedraogo University Hospital Center (YO-UHC), Ouagadougou, Burkina Faso.

DOI: 10.4236/ojbd.2015.54009 PDF HTML XML 3,548 Downloads 4,209 Views

Abstract

Goal: The goal is to evaluate infections associated with central venous catheters of hemodialysis (CRI) in hemodialysis patients in Ouagadougou. Patients and methods: The study was cross-sectional, from February 15th to June 30th, 2015. It was conducted in Ouagadougou (Burkina Faso). We included patients with a new central venous catheter (CVC) inserted in the hemodialysis unit. The timeout for making an arteriovenous fistula (AVF) for chronic hemodialysis in Ouagadougou may exceed six months. The CVCs used at the time of the study were made of polyurethane and non-tunneled. Sociodemographic, clinical and paraclinical data were collected and analyzed. Results: During the study period, 156 CVCs were installed in 114 patients, and the average age was 41.8 ± 17.1 years. A CRI occurred on 39 CVCs for a rate of 9.5/1000 days-catheter. The frequency of CRI was 28.4%, 20.6% and 20% respectively in femoral, jugular, and subclavian veins. The culture of the tip of the catheter was done in 21 cases. Fifteen germs have been identified: eight cases of Gram-positive cocci (53.3%) and seven cases of Gram-negative bacilli (46.7%). It was essentially staphylococci (eight cases). In univariate analysis, a period of use of the CVC in chronic hemodialysis over 10 days was significantly (p = 0.01; r = 2.91) associated with the catheter-related infection (CRI). Conclusion: The impact of the CRI was very high in our series. The associated factor in the univariate analysis was the long period of use of the CVC. The most diligent production of AVFs at the YO-UHC would contribute to a significant reduction of the CRI.

Keywords

Burkina Faso, Catheter, Hemodialysis Delivery Systems, Infections, Staphylococcus

Share and Cite:

Coulibaly, G. , Ilboudo, G. , Sondo, K. , Karambiri, A. , Kissou, F. and Lengani, A. (2015) Factors Associated with Infection of the Central Venous Catheter for Hemodialysis in Ouagadougou (Burkina Faso). Open Journal of Blood Diseases, 5, 59-65. doi: 10.4236/ojbd.2015.54009.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	(2007) 12th Conference of Consensus in Resuscitation and Emergency Updating 2002 Medicine. Definitions of the IAS CTIN-ILS.
[2]	Jon, B. (2012) Central Venous Catheters Temporary Hemodialysis. Doctoral Thesis in Medicine, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University, Morocco. Resuscitation 2012, No. 125112.
[3]	Ould Bezeid, M.M. Assessment of Activities of the Hemodialysis Unit of National Hospital of Point “G” from 1999 to 2001. Medicine, Mali 2003, Thesis. http://www.keneya.net/fmpos/theses/2003/med/pdf/03M05.pdf
[4]	Ge, X., Cavallazzi, R., Li, C., Pan, S.M., Wang, Y.W. and Wang, F.L. (2012) Central Venous Access Sites for the Prevention of Venous Thrombosis, Stenosis and Infection. Cochrane Database of Systematic Reviews 2012, Issue 3.
[5]	Uzan, M. and Avignon, A. (2012) The Central Venous Catheter for Hemodialysis: Recommendations Connections/Disconnections. 8th Annual Day of Exchanges of Network DIALIN Hospital Center South Lyon, Pierre Bénite, 18 September 2012.
[6]	K-DOQI (2006) Clinical Practice Guidelines for Vascular Access. American Journal of Kidney Diseases, 48, 5274-5276.
[7]	Oliver, M.J., Callery, S.M., Thorpe, L.E., Schwab, S.J. and Churchill, D.N. (2000) Risk of Bacteremia from Temporary Hemodialysis Catheters by Site of Insertion and Duration of Use: A Prospective Study. Kidney International, 58, 2543-2545. http://dx.doi.org/10.1046/j.1523-1755.2000.00439.x
[8]	Leou, S.F., Tarela Garnier, P.C., Ramana Lumbroso, S., Shoemaker, C., et al. (2013) French Evaluation of Infectious Complications Associated with Central Venous Catheters for Hemodialysis in Polynesia. Néphrologie & Thérapeutique, 9, 137-142. http://dx.doi.org/10.1016/j.nephro.2013.01.003
[9]	Humar, A., Ostromecki, A. and Direnfeld, J. (2000) Prospective Randomized Trial of 10% Povidone-Iodine versus 0.5% Tincture of Chlorhexidine as Cutaneous Antisepsis for Prevention of Central Venous Catheter Infection. Clinical Infectious Diseases, 31, 1001-1007. http://dx.doi.org/10.1086/318145
[10]	Paglialonga, F., Consolo, S., Biasuzzi, A., Assomou, J., Gattarello, E., Patricelli, M.G., et al. (2014) Reduction in Catheter-Related Infections after Switching from Povidone-Iodine to Chlorhexidine for the Exit-Site Care of Tunneled Central Venous Catheters in Children on Hemodialysis. Hemodialysis International, 18, S13-S18. http://dx.doi.org/10.1111/hdi.12218
[11]	Mimoz, O., Lucet, J.C., Kerforne, T., Pascal, J., Souweine, B., Goudet, V., et al. (2015) Skin Antisepsis with Chlorhexidine-Alcohol versus Povidone Iodine-Alcohol, with and without Skin Scrubbing, for Prevention of Intravascular-Catheter-Related Infection (CLEAN): An Open-Label, Multicentre, Randomised, Controlled, Two-by-Two Factorial Trial. The Lancet, 386, 2069-2077. http://dx.doi.org/10.1016/S0140-6736(15)00244-5
[12]	Maki, D.G., Kluger, D.M. and Crnich, C.J. (2006) The Risk of Bloodstream Infection in Adults with Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies. Mayo Clinic Proceedings, 81, 1159-1171. http://dx.doi.org/10.4065/81.9.1159
[13]	Parienti, J.J., du Cheyron, D. and Timsit, J.F. (2012) Metaanalysis of Subclavian Insertion and Non-Tunneled Central Venous Catheter Associated Infection Risk Reduction in Critically Ill Adults. Critical Care Medicine, 40, 1627-1634.
[14]	Marik, P.E., Flemmer, M. and Harrison, W. (2012) The Risk of Catheter Related Bloodstream Infection with Femoral Venous Catheters as Compared to Subclavian and Internal Jugular Venous Catheters: A Systematic Review of the Literature and Metaanalysis. Critical Care Medicine, 40, 2479-2485. http://dx.doi.org/10.1097/CCM.0b013e31823e99cb
[15]	Dugué, A.E., Levesque, S.P. and Fischer, M.O. (2012) Vascular Access Sites for Acute Renal Replacement in Intensive Care Units. Clinical Journal of the American Society of Nephrology, 7, 70-77. http://dx.doi.org/10.2215/CJN.06570711
[16]	McGee, D. and Gould, M. (2003) Preventing Complications of Central Venous Catheterization. The New England Journal of Medicine, 348, 1123-1133. http://dx.doi.org/10.1056/NEJMra011883
[17]	Cote, D., Lok, C.E., Battistella, M. and Vercaigne, L. (2010) Stability of Trisodium Citrate and Gentamicin Solution for Catheter Locks after Storage in Plastic Syringes at Room Temperature. Canadian Journal of Hospital Pharmacy, 63, 304-311. http://dx.doi.org/10.4212/cjhp.v63i4.934
[18]	Fram, D., Okuno, M.F.P., Taminato, M., Ponzio, V., Manfredi, S.R., Grothe, C., et al. (2015) Risk Factors for Bloodstream Infection in Patients at a Brazilian Hemodialysis Center: A Case-Control Study. BMC Infectious Diseases, 15, 158. http://dx.doi.org/10.1186/s12879-015-0907-y
[19]	Katneni, R. and Hedayati, S.S. (2007) Central Venous Catheter-Related Bacteremia in Chronic Hemodialysis Patients: Epidemiology and Evidence-Based Management. Nature Clinical Practice Nephrology, 3, 256-266.
[20]	Amor, S., Zellama, D., Belkhir, W., Guedri, Y., Mrabet, S., Sabri, F., et al. (2014) Epidemiological Study of Bacterial Infections Related to Jugular Catheters in Hemodialysis. Néphrologie & Thérapeutique, 10, 294. http://dx.doi.org/10.1016/j.nephro.2014.07.009
[21]	Hoen, B., Paul-Dauphin, A., Hestin, D. and Kessler, M. (1998) EPIBACDIAL: A Multicenter Prospective Study of Risk Factors for Bacteremia in Chronic Hemodialysis Patients. Journal of the American Society of Nephrology, 9, 869-876.
[22]	Khosroshahi, H.T., Mahdipur, H., Parkhideh, S., Basmenji, S., Khalilzadeh, M. and Tozihi, M. (2015) The Effectiveness of Systemic Antibiotic Therapy with and without Ethanol-Locked Solution in the Treatment of Hemodialysis-Related Catheter Infection. Saudi Journal of Kidney Diseases and Transplantation, 26, 477-481. http://dx.doi.org/10.4103/1319-2442.157315
[23]	Misanovic, V., Jonuzi, F., Anic, D., Halimic, M. and Rahmanovic, M. (2015) Central Venous Catheter as Vascular Approach for Hemodialysis—Our Experiences. Materia Socio Medica, 27, 112-113. http://dx.doi.org/10.5455/msm.2015.27.112-113
[24]	Nitenberg, G., Jagot, J.L. and Antoun, S. (1991) Pathophysiology and Epidemiology of Infections Associated with Central Venous Catheters. Nutrition & Metabolism, 5, 11-24.